Substrate and cofactor supply for glutathione (GSH) synthesis
GSH Biosynthesis & Regeneration · Redox balance and antioxidant defense
Supplies the key rate-limiting precursors for GSH biosynthesis (L-cysteine, glycine) or the coenzymes and prosthetic groups it needs (NADPH, selenium, riboflavin), maintaining the strongest reducing potential inside cells.
Supplements acting on this mechanism (ranked by strength and evidence)
N-acetylcysteine (NAC)
After deacetylation, NAC provides cysteine and supports GSH synthesis when substrate is limited; this is its defining action. In a randomized, double-blind human trial, GSH was replenished in whole blood and T cells of people with HIV. The effect depends on the tissue and baseline state.
Glycine + NAC complex (GlyNAC)
Glycine and NAC supply the glycine and cysteine needed for glutathione synthesis, which is the core action of this combination. Human trials directly measured improved glutathione levels in red blood cells and muscle at higher doses, but the response depends on baseline status and dose, and it differs considerably between groups of people.
L-selenomethionine
Selenomethionine is metabolized to provide selenium, which is used to build the selenocysteine (Sec) catalytic residue of glutathione peroxidase (GPx). Sec is an amino acid residue within the GPx protein, not a free prosthetic group. Supplemental selenium can raise GPx activity in people who are deficient, but this concerns how GSH is used, not direct GSH synthesis.
Glycine
Glycine is one of the substrates for glutathione synthesis, and human tracer studies show it enters the GSH pool in red blood cells. But most supplementation trials combined it with NAC, so the effect cannot be attributed to glycine alone. Routine supplementation also does not necessarily overcome the rate limit; whether glycine is limiting depends on nutritional status and other substrates.
R-alpha-lipoic acid (R-ALA)
In human trials, higher doses of racemic lipoic acid raised total blood glutathione, but the studies did not distinguish between synthesis, regeneration and transport. Cell studies show it can improve cystine utilization. The specific pathway has not been confirmed in humans, and the results should not be applied directly to usual doses of R-ALA.
Liposomal glutathione
Small human studies measured higher GSH in blood and some cell types after oral liposomal GSH. However, they did not show that intact exogenous GSH enters cells directly, nor did they directly measure the contribution of the synthesis pathway, so how intracellular GSH is replenished remains uncertain.
S-adenosylmethionine (SAMe)
After donating its methyl group, SAMe becomes homocysteine, which the transsulfuration pathway converts to cysteine, indirectly supplying raw material for glutathione synthesis. One small controlled study found higher glutathione in liver biopsies, but another randomized trial found no significant change in serum glutathione.
Pyridoxal 5’-phosphate (active vitamin B6)
PLP is a cofactor for enzymes in the transsulfuration pathway, which indirectly supports cysteine supply. Human studies provide evidence from related metabolic markers, but glutathione does not necessarily rise after supplementation, so this does not mean PLP directly raises antioxidant reserves.
NADH
In the body, NADH can be converted to NADPH through transhydrogenation, supplying electrons to glutathione reductase. This is endogenous metabolism. It is unclear whether oral NADH reaches this step, and no human study has shown that 10–20 mg taken orally increases tissue NADPH or glutathione reduction.
Methylsulfonylmethane (MSM / OptiMSM)
Human studies have found inconsistent changes in plasma glutathione and its ratio after exercise. These changes do not show that MSM sulfur enters the transsulfuration pathway, and there is no evidence that it supplies a substrate or cofactor for GSH synthesis. The sulfur-donor mechanism has not been confirmed.